Welcome to the Cancer Diagnosis Program!
The Cancer Diagnosis Program strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative in vitro diagnostics, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.
For more information about the Cancer Diagnosis Program and its Branches, please click here.
News and Announcements
08/2020
Check out our new funding opportunities from the SBIR! Click here!
10/2019
New publication on submitting diagnostic tissue blocks for NCI clinical trials. Check here for more publications.
08/2019
Check out new funding opportunities from the ITCR! For additional funding opportunities from the CDP, check here.
07/2019
New publication on biostatistical and logistical considerations in the development of basket and umbrella clinical trials. Check here for more publications
06/2019
New publication addressing individual and societal approaches to personalized medicine in oncology. Check here for more publications.
07/2018
Check out new publications by the CDP Staff! Learn more about Circulating Tumor DNA Assays in Clinical Cancer Research, a blog and paper on returning incidental findings in the Genotype-Tissue Expression (GTEx) project, and the fundamental issues of biomarkers in early-phase trials. See what else we’re writing about on our CDP Publications page.
Sign up for Email Updates
Follow us on Twitter
Contact Us